ODOlga Sergeevna Donskaya

Olga Sergeevna Donskaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olga Sergeevna Donskaya has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Topical antiseptic therapy for infectious and inflammatory diseases of the oropharynx and oral cavity: diagnostic minimum and patient routing: a review

    by Sergey V. Ryazantsev, Рязанцев Сергей Валентинович, Svetlana S. Vysockaya, Высоцкая Светлана Сергеевна, Olga S. Donskaya, Донская Ольга Сергеевна, Sergei A. Eremin, Еремин Сергей Алексеевич, Mehrab D. Malekshahian, Малекшахян Мехраб Джабарович

    Inflammatory and infectious diseases of the oropharynx and oral cavity are among the most common reasons for visiting primary care outpatient specialists. The key challenge is the excessively frequent use of systemic antibacterial agents, although in most cases the disease has a viral etiology. This practice directly contributes to the increase in antimicrobial resistance. The aim of this work is to demonstrate the role of local antiseptic therapy as a tool for limiting the growth of resistance and to identify the most appropriate agent for topical use. The available scientific data and clinical guidelines on the problem of antimicrobial resistance were analyzed. A comparative analysis of the mechanisms of inflammatory processes in periodontal tissues and the pharyngeal mucosa was performed. Information on indications, regimens, and criteria for evaluating the effectiveness of local therapy was systematized. Particular attention was paid to such aspects as the diagnostic minimum, patient routing, and outpatient practice in infectious and inflammatory diseases of the oropharynx and infectious and inflammatory diseases of the oral cavity. The management of such conditions as pharyngitis, tonsillitis, stomatitis, and gingivitis was considered. According to the analysis, β-hemolytic group A streptococcus is detected in only 5–15% of adult patients complaining of sore throat, while antibacterial agents are prescribed in 64% of such cases. In this context, rational local antiseptic therapy is of particular importance, as it allows direct action on the inflammatory focus and helps limit the unjustified use of systemic antibacterial agents. The clinical and pharmacological properties of the local antiseptic drug Miramistin® − benzyldimethyl-[3-(myristoylamino)-propyl] ammonium chloride monohydrate − were reviewed. The drug at a concentration of 0.01% demonstrates a broad spectrum of activity against bacteria, fungi, and viruses, exerts an immunomodulatory effect, and does not lead to the development of resistance in pathogens. The use of the drug Miramistin® as the first-choice agent for local antiseptic therapy of infectious and inflammatory lesions of the oropharynx and oral cavity is pathogenetically justified, especially within the framework of a comprehensive approach to patient treatment.

  • Modern approach to rehabilitation of patients with post-implantation sinusitis

    by A. V. Bakotina, A. Yu. Ovchinnikov, O. S. Donskaya

    The relevance of the study is because of the increasing frequency of dental implantation and the associated increase in the development of post-implantation maxillary sinusitis. Objective. To determine the need for removal of bone plastic material in the development of post-implantation sinusitis after subantral augmentation. Materials and methods. This includes an analysis of a clinical case of a patient with post-implantation left-sided maxillary ethmoiditis after sinus lifting and dental implantation, as well as a comprehensive examination that, using CT scan and endoscopic diagnostics. Results. The study demonstrates the possibility of preserving the bone-plastic material after the development of post-implantation sinusitis, provided that adequate conservative therapy or minimally-invasive functional rhinosinus surgery is performed. Conclusions. The development of post-implantation maxillary sinusitis is possible even with a technically correct operation. The key factor in successful treatment is the interdisciplinary collaboration between dentists and otolaryngologists. With timely and appropriate treatment, it is possible to preserve the augmented material while maintaining its functional properties.

  • Interdisciplinary interaction in diagnosis and treatment of maxillary odontogenic cysts

    by A. V. Bakotina, M. O. Dobrokhotova, O. I. Izotov, V. V. Luzina, A. Yu. Drobyshev, O. S. Donskaya

    Relevance. Odontogenic cysts of the jaws are one of the most common pathologies encountered in dental practice. Dentigerous (follicular) cysts account for up to 15% of all cysts. Clinical case. This article is devoted to a clinical case of an odontogenic cyst of the maxillary sinus, which penetrated the maxillary sinus and led to the development of maxillary sinusitis. The paper examines in detail the anatomical features of the maxillary sinus, the patient’s diagnosis and treatment history, and the characteristics of the surgical intervention. This clinical example demonstrates how an incorrect diagnosis and, as a result, an incorrectly chosen surgical volume and tactics led to disease progression. During the initial examination of the paranasal sinuses, a dentigerous cyst was visualized in the left maxillary sinus, which the otolaryngologist likely mistakenly identified as a sinus retention cyst. The doctor chose the appropriate removal method — endoscopic maxillotomy. Odontogenic cysts should be operated on externally because they are alveolar ridge cysts and have a bony wall that is the cortical plate of the alveolar ridge. Discussion. The maxilla is an area of interest for physicians of various specialties, including otolaryngologists, dentists, maxillofacial surgeons, and oncologists. An interdisciplinary approach helps improve the quality of medical care. The knowledge of related colleagues can enrich the experience of young specialists. To minimize diagnostic errors, it is necessary to perform radiographic tomography of the entire maxillofacial region with the involvement of a radiologist and a detailed protocol.

  • Possibilities of cytokine therapy in treatment of comorbid diseases associated with persistent herpesvirus infection

    by I. A. Gorbacheva, Yu. A. Sycheva, O. S. Donskaya, Yu. E. Osintseva, E. S. Ryazantseva

    The search for common links in the etiopathogenesis of comorbid pathology in modern patients is an important problem of scientific and practical medicine and opens up opportunities to improve the effectiveness of their treatment. A study of the nosological structure of combined diseases of the ENT organs and oral cavity showed that herpes infection, especially genotypes 4, 5, 6, 7, parasitizing in immunocytes, is involved in their frequent exacerbations and protracted courses. Chronic infectious and inflammatory diseases in the ENT organs and oral cavity associated with the chronic persistence of herpes viruses form the status of chronically and frequently ill people with severe immunological disorders and cytokine imbalance. The study presents positive experience in the use of polycytokine therapy (PCKT). Objective. To evaluate the state of the interferon system and some interleukins (IL-1, IL-2, IL-6, IL-10) in chronically and frequently ill patients with multiple chronic foci of infection in the ENT organs and oral cavity against the background of chronic persistence of herpes genotypes 4, 5, 6 to determine indications for polycytokine therapy in the complex treatment of polymorbid patients. Materials and methods. The study included 45 patients who were frequently and long-term ill with respiratory diseases (more than 4 cases per year), with serologically proven chronic persistence of herpes infection genotypes 4, 5, 6 against the background of comorbid chronic focal infection in the ENT organs and oral cavity. All patients were assessed for immunological status and blood interferon profile before and after a 6-month course of treatment with PCKT (recombinant alpha- and gamma-interferons, recombinant interleukin). Results. In the observed patients, a significant decrease in the levels of natural killers (NK cells) and natural killers T (NKT cells) as well as activated T- and B-lymphocytes was revealed against the background of a tendency to T-cell lymphocytosis. It was revealed that a decrease in interleukin 2 and hyperproduction of 6 and 10 contribute to immunological deficiency. A significant decrease in the resources of the interferon system was found in all patients (p < 0.01). Polycytokine therapy with recombinant preparations of alpha and gamma interferons with recombinant interleukins led to the restoration of the parameters of the interferon system and was accompanied by an improvement in the immunological parameters of the blood as well as the clinical condition of the patients. Conclusion. Thus, the positive experience of polycytokine therapy by restoring the resources of the interferon system indicates the importance of immunotherapy in comorbid patients with ENT and oral cavity diseases against the background of persistent herpes infection for improving their condition and enhancing their quality of life.

  • Oral cavity changes with proton pump inhibitors in patients with laryngopharyngeal reflux

    by I. A. Gorbacheva, Yu. A. Sycheva, M. V. Titova, Saint Petersburg St Luke’s Clinical Hospital Of Saint Petersburg, O. S. Donskaya

    In modern medicine, proton pump inhibitors (PPIs) are one of the most effective treatments for gastroesophageal reflux disease (GERD) and laryngopharyngeal reflux (LPR). However, gastroenterologists and otolaryngologists often overlook the fact that long-term use of PPIs can contribute to the development of side effects. Although PPIs are generally considered safe, a number of studies conducted in recent years have reported some side effects, including an increased risk of infections, such as intestinal infections. These side effects are believed to be associated with PPI-induced gastrointestinal dysbiosis, which is characterized by excessive growth of bacteria living in the oral cavity. The data obtained suggest that changes in the oral microbiota after taking PPIs can significantly affect the degree of intestinal dysbiosis. The effect of PPIs on oral health in patients with LPR requires further study. Thus, studying changes in the oral microbiota after PPI treatment is crucial to better understand the side effects of PPI use in patients with LPR and optimize treatment plans.

  • Open Access

    Comorbidity of periodontal diseases and atopic dermatitis

    by Olga S. Donskaya, Ekaterina I. Berdnikova

    BACKGROUND: The relationship between periodontal diseases and somatic pathology has been proven. Studies on the link between periodontal and atopic diseases are few, which determines the relevance of this study. AIM: To characterize the relationship between inflammatory periodontal diseases and atopic dermatitis. MATERIALS AND METHODS: Overall, 26,470 full-text publications from 2016 to 2023 on the research topic were found in the databases PubMed, Google Scholar, and eLIBRARY.RU. RESULTS: An analysis of literature data was performed to study the relationship between inflammatory periodontal diseases and atopic dermatitis. On the one hand, the presence of oral pathology in patients with atopic diseases can lead to atopic disease worsening, and on the other hand, an atopic disease can contribute to the development of oral diseases. After conducting a literature search and applying the inclusion and exclusion criteria for the sample, complete overlap of the research topics was found in three publications. The data obtained were contradictory, as two publications established a direct connection between periodontitis and atopic dermatitis and one publication did not. In studies on the research topic on certain aspects, the possible mechanisms of comorbidity of periodontal and atopic diseases are characterized and assessments on the existence of a feedback or direct relationship between these pathologies are presented. CONCLUSION: The periodontal status of patients with atopic dermatitis remains poorly understood, and evidence linking oral diseases to it is ambiguous. The presented studies relatively confirmed the direct connection between periodontal diseases and atopic dermatitis; however, the hygiene hypothesis, that is, there is an inverse relationship between periodontal diseases and atopic diseases, was not confirmed.

  • The influence of oral breathing type on the formation of occlusion in students of general educational institutions of the Ministry of Defense of Russian Federation

    by Natalia А. Sokolovich, Anastasiya A. Saunina, Vladimir V. Dvoryanchikov, Anatoli A. Lunev, Иван K. Soldatov, Olga S. Donskaya

    BACKGROUND: Among students of general education organizations of the Ministry of Defense of Russian Federation, respiratory diseases is the leading cause of general somatic morbidity and amount to 1543.5‰. When examining students, pathology of the upper respiratory tract is often diagnosed, such as partial or complete obstruction of the nasopharynx and/or oropharynx. Against this background, the formation of the oral type of breathing occurs, which affects the state of general somatic health and growth and development of the facial skeleton. AIM: To evaluate the influence of oral breathing on the dentoalveolar and gnathic parameters of the maxillofacial region in students of educational institutions of the Ministry of Defense of Russian Federation. MATERIALS AND METHODS: This study examined two groups of students aged 13–15 years from the St. Petersburg Cadet Military Corps named after Prince Alexander Nevsky: group 1, 30 cadets with oral breathing, and group 2 (control), 30 cadets with nasal breathing. All patients underwent an examination of the oral cavity, a photo protocol, scanning of the dentition, and cone-beam computed tomography of the skull bones and first cervical vertebrae in natural occlusion with a resolution of 17×15. The data were checked for normal distribution of features. The article presents arithmetic averages and their errors (M±m). RESULTS: All the examined group 1 students with oral breathing were diagnosed with distal bite in combination with other dental anomalies: combined anomalies in the form of distal bite and disocclusion in the frontal region (56.7%); close position of the anterior group of teeth (93.3%); and unilateral (30.0%) and bilateral (13.3%) cross occlusion due to narrowing of the upper and lower jaws. In most cases, the group 1 students were diagnosed with a gnathic form of dentoalveolar anomaly (ANB parameter, 6.6±2.4°; Beta parameter, 24.7±3.1°) against the background of retroposition of the lower jaw (SNB parameter, 75.4±2.8°) and a decrease in the length of the lower jaw (Co–Gn parameter, 106.0±2.8 mm). All the group 2 (control) students had a neutral occlusion with a normal position of the upper jaw (SNA parameter, 81.4±2.1°) and a normal position of the lower jaw (SNB parameter, 79.8±1.6°) and the first skeletal class (ANB parameter, 2.3±1.1°; Beta parameter, 30.1±2.5°). CONCLUSION: Oral breathing is accompanied by the development of disto-occlusion with the formation of a vertical gap in combination with cross occlusion in the lateral sections and close position of the anterior group of teeth against the background of a narrowing of the upper and lower jaws. Prompt diagnosis of upper respiratory tract pathology prevents the development of dentoalveolar and gnathic disorders of the maxillofacial area. To treat patients with oral breathing, a simultaneous approach is required with the involvement of a full-time otolaryngologist at the medical center.

  • Open Access

    Current views on treatment of halitosis: foreign practice

    by Olga Sergeevna Donskaya, Ekaterina Igorevna Berdnikova, Vera Anatolyevna Osipova, Taras Mikhailovich Markvashev

    Traditional halitosis treatment involves reducing microbial contamination through chemical and/or mechanical action; however, these methods are ineffective in the long-term. According to recent systematic reviews, there is no scientific evidence of the effectiveness of halitosis treatments, and even when reports indicate a positive effect, it is temporary. To increase the number of studies being compared, analysis of the results of randomized controlled trials (RCTs) should be performed considering already published data. Therefore, a review of recent RCTs is required for conducting and planning further scientific research on halitosis treatment. Purpose of the investigation — to study the effectiveness of oral halitosis treatment based on materials from foreign publications from 2019 to 2023. This article provides a descriptive review of foreign scientific publications on modern methods of treating oral halitosis. A search for full-text articles was conducted in the electronic databases PubMed and Google Scholar for 2019–2023. The most relevant articles that met the selection criteria were selected and included in this review: 31 publications on oral halitosis treatment: 3 Cochrane reviews of RCTs; 14 literature reviews, including meta-analyses; 12 RCTs and clinical studies; and 2 experimental studies. In foreign studies, the use of probiotics and photodynamic therapy and their combination with standard treatment methods are most widely presented; RCTs have established their effectiveness, especially when used together with traditional methods of mechanical tongue cleaning. To prevent halitosis, it appears relevant to use materials with antibacterial properties in prosthetics, particularly the modification of polymethyl methacrylate with silver and graphene nanoparticles. However, against the backdrop of positive results obtained in individual reviews, the conclusions of systematic reviews are contradictory. There is no evidence of the long-term effectiveness of the proposed treatment methods, and there is a weak evidence base for studies, which makes it challenging to use them in the practical work of dentists. In this regard, new RCTs with a longer observation period and considering published data are required.

  • Open Access

    Features of the treatment of acute otitis media in the COVID-19 pandemic

    by S. V. Ryazantsev, I. V. Tkachuk, А. E. Golovanov, P. V. Kireev, K. A. Balatskaya, O. S. Donskaya

    In the pandemic new coronavirus infection (COVID-19), different clinical symptoms are observed depending on its dominant strain. The Omicron strain affects the nasal mucosa, causing the possibility of complications such as tubootitis and acute otitis media. Untimely or incomplete treatment of otitis media can contribute to the development of chronic forms of the course. Inflammatory process in the middle ear always proceeds with impaired hearing function due to the development of adhesions in the tympanic cavity. In patients with a reduced immune status, weakened course of the coronavirus infection itself, recovery comes later with a long recovery of hearing acuity, so it is very important to start treatment at the first manifestations of pain in the ear. In addition, the danger of otitis media against the background of SARS-CoV-2, if not treated in time, is the development of serious complications – mastoiditis, meningeal syndrome. Local analgesic therapy in the form of analgesic ear drops is recommended to reduce inflammation of the eardrum tissues. The combination of phenazone and lidocaine allows you to quickly stop the pain, block the development of phases of inflammation in the middle ear. Using a combination of phenazone and lidocaine reduces the time of onset of the analgesic effect, while increasing the intensity and duration of action, which is very important, especially in children. These components are not resorbed and have no systemic effect on the patient’s body. The combination of phenazone and lidocaine can be used in the treatment of children of all age groups, adults, pregnant women and nursing mothers.


  • Features of body’s immunoreactivity in post-covid period in polymorbid patients with chronic foci of infection of ent organs and oral cavity

    by I. A. Gorbacheva, I. N. Antonova, Yu. A. Sycheva, Ya. E. Osintseva, O. S. Donskaya, E. S. Ryazantseva, A. E. Kasatkin, Saint Petersburg St. Luke Clinical Hospital

    The high level of morbidity and labor losses among the population during the epidemic of a new coronavirus infection is largely determined by the protracted course of the post-COVID syndrome, which is often complicated by the exacerbation of chronic foci of infection of the upper respiratory tract and oral cavity. Clinical manifestations of a developed immunodeficiency state require an assessment of the characteristics of the body’s immunoreactivity in patients who have undergone COVID-19 in order to develop targeted programs for their immunorehabilitation and prevent manifestations of chronic focal infection, which was the purpose of the study. Immunological examination of 37 patients aged 42 to 60 years (53 ± 3.8 years), 24 women and 13 men, in the post-COVID period with exacerbation of chronic ENT infection (nasopharyngitis, sinusitis, otitis media, laryngitis) and dental pathology (generalized inflammatory periodontal disease, apical granulomas) showed the formation of an immunological imbalance with a quantitative deficiency of T-helpers with a high level of cytotoxic T-lymphocytes and NK cells expressing the alpha chain of the CD8 antigen as well as cytokine-producing NK cells against the background of a pronounced decrease in the resources of alpha and gamma interferon and a high level of Ig E and CIC in the blood. The established immunological prerequisites for comorbid infection, allergization, autoimmunization, and chronic sequel of inflammatory response motivated approaches to the rehabilitation of patients in the post-COVID period and the prevention of activation of chronic foci of infection in the ENT organs and oral cavity through sequential detoxification and immunocorrection. The positive experience of using bioactive preparations of natural origin with a complex detoxifying, immunotropic, antioxidant, and adaptogenic action is presented.